SPOTLIGHT -
Recently, several manufacturers of insulin pens for diabetes treatment have added warnings to the devices, cautioning against their use by visually impaired patients.
SCHWIND appoints new head of global marketing solutions
Lohith Shetty will lead marketing for the company, based in Kleinostheim, Germany
Novel Therapies in Neovascular AMD and DME: Achieving Superior Anatomic Outcomes with Fewer Injections
Cataract surgery pre-treatment with miLoop: Shorter lensectomy time, less irrigation needed
Investigators presented research on the pre-treatment outcomes during the 2024 ASCRS meeting
Long-Term Efficacy and Durability of Latest Therapies in neovascular AMD and DMO
Carl Zeiss Meditec AG announces completed acquisition of Dutch Ophthalmic Research Center
Zeiss has secured regulatory approvals to acquire DORC and will shift focus to integration implementation
Use of AI to redirect school-aged children during screen time